← Back
$AUPH All transactions

Aurinia Pharmaceuticals Inc.

A

$ Value

$0

Shares

165,384

Price

$0

Filed

Jan 5

Insider

Name

Greenleaf Peter

Title

Chief Executive Officer

CIK

0001363683

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,954,329

Footnotes

Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026. | Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards. | Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,257 common shares were acquired on May 30, 2025 and 1,620 common shares were acquired on November 28, 2025.

Filing Info

Accession No.

0001600620-26-000002

Form Type

4

Issuer CIK

0001600620

Greenleaf Peter's History

Date Ticker Type Value
2026-04-02 PTHS $9K
2026-04-02 PTHS $8K
2026-03-02 AUPH F $1.4M
2026-02-27 AUPH A $0
2026-02-27 AUPH A $0
2026-02-20 AUPH F $1.4M
2026-01-02 AUPH A $0
2026-01-02 AUPH F $1.8M
2025-07-02 PTHS A $0
2025-07-02 PTHS A

Other Insiders at AUPH (90d)

Insider Bought Sold Last
TANG KEVIN $12.7M 2026-03-03
Greenleaf Peter
Chief Executive Officer
2026-03-02
Donley Matthew Maxwell
Chief Operating Officer
2026-03-02
Miller Joseph M
Chief Financial Officer
2026-03-02
Robertson Stephen P.
EVP, General Counsel
2026-03-02
Keenan Greg
SVP, Chief Medical Officer
2026-03-06